Sttr PH II topic & prototype development - human performance optimization

Ended Definitive Contract Awarded Last action

Contract number
H9240519C0010
Awardee
Awarding agency
Obligated
$2,220,133

Award facts

Contract value 100% obligated
$2,220,133.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 3 offers Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
San Diego, CA 92121, USA
Research
STTR Phase II
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00005 · Sttr PH II topic & prototype development.add cap line and exhibit $0
Vendor Address Change ARZ997 $0
Other Administrative Action P00004 · Sttr PH II topic & prototype development remove 252.242.-7005 (not applicable) $0
Supplemental Agreement for work within scope P00003 · 2 week extension due to covid travel restriction. Sttr PH II topic & prototype development $0
Supplemental Agreement for work within scope P00002 · Overrun cost, no change in scope. Sttr PH II topic & prototype development $775,076
Supplemental Agreement for work within scope P00001 · Extension due to covid-19 closures and necessity of social distancing. Sttr PH II topic 17C-001 human performance optimization $0
Original award $1,445,057

About this award

Rejuvenate Bio Inc., a for-profit small business, was awarded a $2,220,133.00 cost-plus-fixed-fee contract by the United States Special Operations Command (USSOCOM) to conduct Small Business Technology Transfer (STTR) Phase II research and prototype development related to neuroenhancement and human performance optimization technologies. The award, which was designated as a total small business set-aside, supports Rejuvenate Bio's ongoing research initiatives aimed at enhancing the capabilities of special operations forces. The contract has a period of performance from March 2019 through August 2021.

Quick answers

Who was awarded contract H9240519C0010?

H9240519C0010 was awarded to Rejuvenate Bio Inc. by US Special Operations Command (Department of Defense) on March 4, 2019.

How much is contract H9240519C0010 worth?

The government has obligated $2,220,133 on H9240519C0010.

Was contract H9240519C0010 competed?

The extent of competition for H9240519C0010 was full and open competition after exclusion of sources. The government received 3 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award